Show simple item record

dc.contributor.authorSzabo, Gyongyi
dc.contributor.authorDolganiuc, Angela
dc.contributor.authorDai, Qun
dc.contributor.authorPruett, Stephen B.
dc.date2022-08-11T08:09:32.000
dc.date.accessioned2022-08-23T16:34:52Z
dc.date.available2022-08-23T16:34:52Z
dc.date.issued2007-01-24
dc.date.submitted2009-03-16
dc.identifier.citation<p>J Immunol. 2007 Feb 1;178(3):1243-9.</p>
dc.identifier.issn0022-1767 (Print)
dc.identifier.doi10.4049/jimmunol.178.3.1243
dc.identifier.pmid17237368
dc.identifier.urihttp://hdl.handle.net/20.500.14038/38430
dc.description.abstractEthanol (EtOH) is the most widely abused substance in the United States, and it contributes to well-documented harmful (at high dosages) and beneficial (at low dosages) changes in inflammatory and immune responses. Lipid rafts have been implicated in the regulation and activation of several important receptor complexes in the immune system, including the TLR4 complex. Many questions remain about the precise mechanisms by which rafts regulate the assembly of these receptor complexes. Results summarized in this review indicate that EtOH acts by altering the LPS-induced redistribution of components of the TLR4 complex within the lipid raft and that this is related to changes in actin cytoskeleton rearrangement, receptor clustering, and subsequent signaling. EtOH provides an example of an immunomodulatory drug that acts at least in part by modifying lipid rafts, and it could represent a model to probe the relationships between rafts, receptor complexes, and signaling.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=17237368&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.4049/jimmunol.178.3.1243
dc.subjectCytoskeleton
dc.subjectEthanol
dc.subjectHumans
dc.subjectImmune System
dc.subjectMembrane Microdomains
dc.subjectReceptors, Immunologic
dc.subjectToll-Like Receptor 4
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleTLR4, ethanol, and lipid rafts: a new mechanism of ethanol action with implications for other receptor-mediated effects
dc.typeJournal Article
dc.source.journaltitleJournal of immunology (Baltimore, Md. : 1950)
dc.source.volume178
dc.source.issue3
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/1298
dc.identifier.contextkey782969
html.description.abstract<p>Ethanol (EtOH) is the most widely abused substance in the United States, and it contributes to well-documented harmful (at high dosages) and beneficial (at low dosages) changes in inflammatory and immune responses. Lipid rafts have been implicated in the regulation and activation of several important receptor complexes in the immune system, including the TLR4 complex. Many questions remain about the precise mechanisms by which rafts regulate the assembly of these receptor complexes. Results summarized in this review indicate that EtOH acts by altering the LPS-induced redistribution of components of the TLR4 complex within the lipid raft and that this is related to changes in actin cytoskeleton rearrangement, receptor clustering, and subsequent signaling. EtOH provides an example of an immunomodulatory drug that acts at least in part by modifying lipid rafts, and it could represent a model to probe the relationships between rafts, receptor complexes, and signaling.</p>
dc.identifier.submissionpathoapubs/1298
dc.contributor.departmentDepartment of Medicine, Division of Gastroenterology
dc.source.pages1243-9


This item appears in the following Collection(s)

Show simple item record